Clinical Trial

Acute Effects of Exercise in Peripheral Arterial Disease Patients

Study acronym: VESSEL-FIT
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 1, 2025 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
Peripheral arterial disease (PAD) affects over 200 million people worldwide and is caused by narrowing of the arteries. Intermittent claudication, characterized by pain when walking, is its main symptom. Despite the proven benefits of exercise, there is no optimal protocol for treatment. To analyze the effects of different exercise conditions on proteomic and physiological markers in patients with PAD and to determine their preferences regarding exercise conditions. A clinical cross-over study with four randomized experimental conditions (aerobic training, traditional strength training, circuit training and control) will be conducted. Patients with grade IIa-IIb PAD according to the Leriche-Le Fontaine scale will be recruited from the Department of Angiology and Vascular Surgery Department of the Hospital Clínico Universitario de Valladolid. In each experimental session, measurements of cardiorespiratory capacity, post-exercise oxygen debt, ankle-brachial index, blood flow, peripheral oxygen saturation, perceived exertion, heart rate variability and blood proteome changes will be performed.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-21.
Trial Details
NCT Number NCT07248137
Lead Sponsor European University Miguel de Cervantes
Collaborators: Hospital Clínico Universitario de Valladolid. Angiology and Vascular Surgery Department.
Conditions Aerobic Physical Exercise, Traditional Strength Exercise, Circuit Strength Exercise, Control
Enrollment 16 participants
Start Date 2025-12-01
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-01